Lipid biochemistry takes a stand against tuberculosis.
Draper
P
P
D000123:Acetyltransferases / Q000037:antagonists & inhibitors; D000995:Antitubercular Agents / Q000378:metabolism / Q000627:therapeutic use*; D001426:Bacterial Proteins; D004359:Drug Therapy, Combination; D054889:Fatty Acid Synthase, Type II; D064429:Fatty Acid Synthases / Q000037:antagonists & inhibitors*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors; D011355:Prodrugs / Q000627:therapeutic use; D011718:Pyrazinamide / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D001426:Bacterial Proteins; D009097:Multienzyme Complexes; D011355:Prodrugs; D011718:Pyrazinamide; C005296:pyrazinoic acid; D000123:Acetyltransferases; D064429:Fatty Acid Synthases; D054889:Fatty Acid Synthase, Type II; C413881:fatty acid synthase I, mycobacteria; D007538:Isoniazid